Harnessing the power of the electronic health record for <scp>ALS</scp> research and quality improvement: <scp>CReATe CAPTURE‐ALS</scp> and the <i><scp>ALS</scp> Toolkit</i>
Volkan Granit(Biohaven Pharmaceuticals (United States)), Michael Benatar(University of Miami), Sumaira Hussain, David Walk(University of Minnesota Medical Center), James B. Caress(The University of Texas at San Antonio Health Science Center), Nancy A. Smider(Epic Systems (United States)), Carlayne E. Jackson(The University of Texas at San Antonio Health Science Center), Tom Yosick(Epic Systems (United States)), Jessica Hernández(University of Miami), Joanne Wuu(University of Miami), Jonathan Katz(The University of Texas at San Antonio Health Science Center), Anne‐Laure Grignon(University of Miami)
Cited by 8
Related Papers
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
|The Lancet Neurology|2023|255
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
|Neurology|2020|201
Venous Thromboembolism Prophylaxis after Head and Spinal Trauma: Intermittent Pneumatic Compression Devices Versus Low Molecular Weight Heparin
|World Journal of Surgery|2004|149